These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 38166643)
1. Prognostic significance of 18F-Fluorodeoxyglucose positron-emission tomography parameters in patients with biliary tract cancers: a meta-analysis. Zheng X; Shi Y; Kulabieke D; Wang Z; Cheng Y; Qian J BMC Med Imaging; 2024 Jan; 24(1):9. PubMed ID: 38166643 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patients. Zschaeck S; Li Y; Lin Q; Beck M; Amthauer H; Bauersachs L; Hajiyianni M; Rogasch J; Ehrhardt VH; Kalinauskaite G; Weingärtner J; Hartmann V; van den Hoff J; Budach V; Stromberger C; Hofheinz F PLoS One; 2020; 15(7):e0236841. PubMed ID: 32730364 [TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer. Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420 [TBL] [Abstract][Full Text] [Related]
4. Combined pre-treatment MRI and 18F-FDG PET/CT parameters as prognostic biomarkers in patients with cervical cancer. Miccò M; Vargas HA; Burger IA; Kollmeier MA; Goldman DA; Park KJ; Abu-Rustum NR; Hricak H; Sala E Eur J Radiol; 2014 Jul; 83(7):1169-1176. PubMed ID: 24767630 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of 18F-FDG PET/CT in malignant pleural mesothelioma: a meta-analysis. Wang Y; Xu Y; Kan Y; Wang W; Yang J Acta Radiol; 2023 Feb; 64(2):552-562. PubMed ID: 35315714 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of 18F-FDG-PET/CT parameters in patients with pancreatic carcinoma: A systematic review and meta-analysis. Zhu D; Wang L; Zhang H; Chen J; Wang Y; Byanju S; Liao M Medicine (Baltimore); 2017 Aug; 96(33):e7813. PubMed ID: 28816978 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis. Liu J; Dong M; Sun X; Li W; Xing L; Yu J PLoS One; 2016; 11(1):e0146195. PubMed ID: 26727114 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Metabolic and Volumetric Parameters of Preoperative FDG-PET/CT in Patients With Resectable Pancreatic Cancer. Im HJ; Oo S; Jung W; Jang JY; Kim SW; Cheon GJ; Kang KW; Chung JK; Kim EE; Lee DS Medicine (Baltimore); 2016 May; 95(19):e3686. PubMed ID: 27175707 [TBL] [Abstract][Full Text] [Related]
9. Mi L; Zhao Y; Zhao X; Yin F; Yin X; Li N; Shi J; Han X; Duan X; Zhao M; Han G; Wang J Cancer Biother Radiopharm; 2021 Oct; 36(8):662-671. PubMed ID: 32783634 [No Abstract] [Full Text] [Related]
10. Metabolic parameters of [ Markus M; Sartor H; Bjurberg M; Trägårdh E Acta Oncol; 2023 Feb; 62(2):180-188. PubMed ID: 36815676 [TBL] [Abstract][Full Text] [Related]
11. Prognostic prediction by Hu R; Zhang Y; Liu S; Lee P; Liu C; Liu A Front Oncol; 2023; 13():1208531. PubMed ID: 37519817 [TBL] [Abstract][Full Text] [Related]
12. Prognostic value of MTV and TLG of 18 F-FDG PET in patients with head and neck squamous cell carcinoma: A meta-analysis. Jin A; Lin X; Yin X; Cui Y; Ma L Medicine (Baltimore); 2022 Sep; 101(39):e30798. PubMed ID: 36181127 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of baseline Xia L; Li X; Zhu J; Gao Z; Zhang J; Yang G; Wang Z Radiat Oncol; 2023 Feb; 18(1):41. PubMed ID: 36829219 [TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of Pretreatment Metabolic Tumor Volume and Total Lesion Glycolysis Using 18F-FDG PET/CT in Patients With Metastatic Renal Cell Carcinoma Treated With Anti-Vascular Endothelial Growth Factor-Targeted Agents. Hwang SH; Cho A; Yun M; Choi YD; Rha SY; Kang WJ Clin Nucl Med; 2017 May; 42(5):e235-e241. PubMed ID: 28288043 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of metabolic tumour volume and total lesion glycolysis measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in small cell lung cancer: A systematic review and meta-analysis. Nie K; Zhang YX; Nie W; Zhu L; Chen YN; Xiao YX; Liu SY; Yu H J Med Imaging Radiat Oncol; 2019 Feb; 63(1):84-93. PubMed ID: 30230710 [TBL] [Abstract][Full Text] [Related]
17. High Metabolic Tumour Volume on 18-Fluorodeoxyglucose Positron Emission Tomography Predicts Poor Survival from Neuroendocrine Neoplasms. Chan DL; Bernard EJ; Schembri G; Roach PJ; Johnson M; Pavlakis N; Clarke S; Bailey DL Neuroendocrinology; 2020; 110(11-12):950-958. PubMed ID: 31711058 [TBL] [Abstract][Full Text] [Related]
18. Early Metabolic Response Assessed Using 18F-FDG-PET/CT for Image-Guided Intracavitary Brachytherapy Can Better Predict Treatment Outcomes in Patients with Cervical Cancer. Kim N; Park W; Cho WK; Bae DS; Kim BG; Lee JW; Kim TJ; Choi CH; Lee YY; Cho YS Cancer Res Treat; 2021 Jul; 53(3):803-812. PubMed ID: 33321566 [TBL] [Abstract][Full Text] [Related]
19. The correlation of Qu YH; Long N; Ran C; Sun J Clin Transl Oncol; 2021 Mar; 23(3):620-627. PubMed ID: 32683540 [TBL] [Abstract][Full Text] [Related]
20. Whole Body Metabolic Tumor Volume and Total Lesion Glycolysis Predict Survival in Patients with Adrenocortical Carcinoma. Satoh K; Patel D; Dieckmann W; Nilubol N; Kebebew E Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S714-20. PubMed ID: 26282908 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]